Tatiane Assone

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Asymptomatic is not silent: proposal of HTLV-1-associated multiple inflammatory disease as an early neuroinflammatory state.

Asymptomatic is not silent: proposal of HTLV-1-associated multiple inflammatory disease as an early neuroinflammatory state.

Journal: Expert review of anti-infective therapy

Published: June 25, 2026

Spontaneous lymphoproliferation differentiates two groups of HTLV-1 asymptomatic carriers: with and without high cell proliferation and death.

Spontaneous lymphoproliferation differentiates two groups of HTLV-1 asymptomatic carriers: with and without high cell proliferation and death.

Journal: Immunologic research

Published: May 05, 2026

Use of dolutegravir to treat people living with HTLV-1-associated myelopathy (HAM).

Use of dolutegravir to treat people living with HTLV-1-associated myelopathy (HAM).

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 21, 2026

Targeted screening for HTLV-1 infection in endemic and non-endemic regions: a global public health priority.

Targeted screening for HTLV-1 infection in endemic and non-endemic regions: a global public health priority.

Journal: Expert review of anti-infective therapy

Published: February 19, 2026

Integrated in vitro and multi-cohort cross-omics analysis of HTLV-1-associated lung pathology reveals a RelA-dependent mechanism for monocyte recruitment and differentiation.

Integrated in vitro and multi-cohort cross-omics analysis of HTLV-1-associated lung pathology reveals a RelA-dependent mechanism for monocyte recruitment and differentiation.

Journal: Molecular medicine (Cambridge, Mass.)

Published: January 08, 2026

Molecular biomarkers associated with ATLL and HAM progression in HTLV-1 infection: a systematic review.

Molecular biomarkers associated with ATLL and HAM progression in HTLV-1 infection: a systematic review.

Journal: Revista do Instituto de Medicina Tropical de Sao Paulo

Published: September 09, 2025

Multi-cohort cross-omics analysis reveals disease mechanisms and therapeutic targets in HTLV-1-associated myelopathy, a neglected retroviral neuroinflammatory disorder.

Multi-cohort cross-omics analysis reveals disease mechanisms and therapeutic targets in HTLV-1-associated myelopathy, a neglected retroviral neuroinflammatory disorder.

Journal: Research square

Published: May 09, 2025

Persistent Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection in the Placenta of Pregnant Women.

Persistent Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection in the Placenta of Pregnant Women.

Journal: Journal of medical virology

Published: February 06, 2025

HTLV-1 and HTLV-2 infections significantly alter small RNA expression in asymptomatic carriers.

HTLV-1 and HTLV-2 infections significantly alter small RNA expression in asymptomatic carriers.

Journal: Frontiers in medicine

Published: December 18, 2024

Adult T-cell lymphoma/leukemia following infective dermatitis in an adult with HTLV-1 infection: a case report.

Adult T-cell lymphoma/leukemia following infective dermatitis in an adult with HTLV-1 infection: a case report.

Journal: Anais brasileiros de dermatologia

Published: October 23, 2024

Brazil takes a leap towards the elimination of HTLV-1 vertical transmission.

Brazil takes a leap towards the elimination of HTLV-1 vertical transmission.

Journal: Lancet regional health. Americas

Published: June 13, 2024

IL-10 predicts incident neuroinflammatory disease and proviral load dynamics in a large Brazilian cohort of people living with human T-lymphotropic virus type 1.

IL-10 predicts incident neuroinflammatory disease and proviral load dynamics in a large Brazilian cohort of people living with human T-lymphotropic virus type 1.

Journal: Frontiers in immunology

Published: April 12, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026